Cutaneous malignant melanoma

被引：255

作者：

Cummins, DL

Cummins, JM

Pantle, H

Silverman, MA

Leonard, AL

Chanmugam, A

机构：

[1] Johns Hopkins Sch Med, Dept Emergency Med, Baltimore, MD 21287 USA

[2] Johns Hopkins Sch Med, Dept Dermatol, Baltimore, MD 21287 USA

[3] Johns Hopkins Sch Med, Dept Cellular & Mol Med, Baltimore, MD 21287 USA

[4] St Agnes Hosp, Dept Emergency Med, Baltimore, MD USA

[5] NYU, Dept Dermatol, New York, NY 10016 USA

来源：

MAYO CLINIC PROCEEDINGS | 2006年 / 81卷 / 04期

关键词：

D O I：

10.4065/81.4.500

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Skin cancer has become the most common neoplasm in the United States. With early diagnosis and appropriate management, most skin cancers have an overall 5-year survival rate of 95%. Cutaneous malignant melanoma (CMM), however, has a significantly higher morbidity and mortality, resulting in 65% of all skin cancer deaths. Although the long-term survival rate for patients with metastatic melanoma Is only 5%, early detection of CMM carries an excellent prognosis, with surgical excision often being curative. Primary care physicians can play a critical role in reducing morbidity and mortality from CMM by recognizing patients at risk, encouraging the adoption of risk-reducing behaviors, and becoming adept at Identifying suspicious lesions.

引用

页码：500 / 507

页数：8

共 87 条

[61] Sentinel node biopsy for early-stage melanoma - Accuracy and morbidity in MSLT-I, an international multicenter trial [J].